What is OptraSCAN?
OptraSCAN is a pioneering digital pathology company dedicated to transforming the future of pathology services through advanced digital slide scanners and AI-driven solutions. The company's innovative technologies offer high-speed, precise imaging and analysis that streamline lab workflows, enhance diagnostic accuracy, and improve patient outcomes. This focus on cutting-edge digital pathology positions OptraSCAN as a key player in the evolving landscape of medical diagnostics.
How much funding has OptraSCAN raised?
OptraSCAN has raised a total of $30.1M across 2 funding rounds:
Debt
$124K
Series B
$30M
Debt (2021): $124K with participation from PPP
Series B (2024): $30M led by Molbio Diagnostics Pvt
Key Investors in OptraSCAN
Molbio Diagnostics Pvt
Molbio Diagnostics is a pioneering company focused on redefining global healthcare through innovative point-of-care technology solutions that decentralize healthcare by providing gold-standard diagnostics directly to patients. Their product offerings include the Truenat platform, which enables rapid and accurate testing for multiple infectious diseases, and other diagnostic tools designed for use in low-resource settings. With a commitment to research and development, Molbio aims to enhance equitable access to healthcare, having positively impacted over 40 million lives across more than 85 countries. Their target clients include healthcare professionals and organizations seeking advanced diagnostic solutions to improve patient outcomes.
PPP
Public-Private Partnership
What's next for OptraSCAN?
With this major enterprise-level funding, OptraSCAN is poised for significant expansion and further development of its AI-driven diagnostic solutions. The strategic investment will likely accelerate the company's go-to-market strategies, enhance its research and development capabilities, and broaden its global reach. This capital will empower OptraSCAN to solidify its position as a leader in digital pathology, driving innovation and improving patient care worldwide.
See full OptraSCAN company page
